How cholesterol in tumors affects immune T-cells
Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion
This study is looking at how too much cholesterol in tumors can tire out important immune cells called CD8+ T-cells that help fight cancer, and it aims to find ways to boost these cells' ability to attack cancer in patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10673683 on NIH RePORTER |
What this research studies
This research investigates how high levels of cholesterol in tumor environments can lead to the exhaustion of CD8+ T-cells, which are crucial for fighting cancer. The study examines the differences in cholesterol content among various T-cell populations within tumors and how this affects their ability to attack cancer cells. By understanding these mechanisms, the research aims to identify potential therapeutic strategies to enhance T-cell function in cancer patients. The approach includes analyzing tumor samples from both mice and humans to draw meaningful conclusions.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with melanoma or multiple myeloma who are undergoing immune-based therapies.
Not a fit: Patients with non-cancerous conditions or those not receiving immune-based treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve the effectiveness of immune therapies for cancer patients.
How similar studies have performed: Other research has shown promising results in understanding the role of the tumor microenvironment in T-cell function, suggesting that this approach could yield significant insights.
Where this research is happening
Houston, United States
- Methodist Hospital Research Institute — Houston, United States (Active)
Researchers
- Principal investigator: Yi, Qing — Methodist Hospital Research Institute
- Study coordinator: Yi, Qing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.